Table 7.
Liver failure type | Index | Mean (before and after) | Standard deviation (front and back) | The value of P |
---|---|---|---|---|
acute hepatic failure | ALT(U/L) | 130.00, 76.33 | 147.77, 51.69 | 0.08 |
AST(U/L) | 180.50, 100.17 | 117.18, 52.11 | 0.028∗ | |
ALB(g/L) | 31.82, 25.98 | 3.26, 1.06 | 0.042∗ | |
ALP(U/L) | 124.33, 93.00 | 24.19, 21.93 | 0.027∗ | |
r-GT(U/L) | 139.83, 79.83 | 30.65, 18.14 | 0.028∗ | |
TBil(umol/L) | 383.88, 206.82 | 127.49, 71.11 | 0.028∗ | |
PT(s) | 19.12, 16.87 | 2.50, 1.03 | 0.046∗ | |
| ||||
subacute hepatic failure | ALT(U/L) | 427.67, 313.67 | 20.79, 104.18 | 0.285 |
AST(U/L) | 343.67, 367.33 | 24.66, 267.99 | 1.00 | |
ALB(g/L) | 34.83, 28.00 | 2.60, 7.43 | 0.109 | |
ALP(U/L) | 117.00, 67.67 | 22.61, 21.50 | 0.109 | |
r-GT(U/L) | 56.33, 31.67 | 12.50, 13.58 | 0.109 | |
TBil(umol/L) | 633.90, 384.87 | 67.76, 80.85 | 0.109 | |
PT(s) | 37.77, 20.17 | 4.80, 1.80 | 0.109 | |
| ||||
acute-on-chronic liver failure | ALT(U/L) | 272.90, 88.00 | 469.06, 56.50 | 0.008∗∗ |
AST(U/L) | 371.20, 187.80 | 506.46, 193.74 | 0.005∗∗ | |
ALB(g/L) | 33.24, 29.85 | 1.92, 1.74 | 0.007∗∗ | |
ALP(U/L) | 74.00, 66.00 | 36.24, 25.79 | 0.541 | |
r-GT(U/L) | 70.50, 54.80 | 20.70, 13.10 | 0.047∗ | |
TBil(umol/L) | 559.37, 408.53 | 380.74, 321.44 | 0.005∗∗ | |
PT(s) | 20.24, 15.37 | 6.26, 1.53 | 0.028∗ | |
| ||||
Chronic liver failure | ALT(U/L) | 37.8, 37.53 | 27.83, 18.69 | 0.955 |
AST(U/L) | 97.20, 78.20 | 90.85, 76.31 | 0.019∗ | |
ALB(g/L) | 28.60, 27.86 | 6.21, 1.96 | 0.394 | |
ALP(U/L) | 89.00, 80.13 | 28.71, 23.39 | 0.053 | |
r-GT(U/L) | 41.40, 36.40 | 19.73, 18.53 | 0.033∗ | |
TBil(umol/L) | 319.73, 223.11 | 145.33, 79.61 | 0.001∗∗∗ | |
PT(s) | 24.06, 17.86 | 5.78, 2.60 | 0.001∗∗∗ |
Note.∗Compared with the preclinical indexes in the treatment of plasma exchange P < 0.05. ∗∗Compared with the preclinical indexes in the treatment of plasma exchange P < 0.01. ∗∗∗Compared with the preclinical indexes in the treatment of plasma exchange P ⩽ 0.001. There was significant statistical significance.